Suppr超能文献

用于评估类固醇生成途径动力学的体外稳态系统:CYP11B1、CYP11B2 和 CYP17 抑制剂的应用。

A steady state system for in vitro evaluation of steroidogenic pathway dynamics: Application for CYP11B1, CYP11B2 and CYP17 inhibitors.

机构信息

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Department of Pediatrics, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

J Steroid Biochem Mol Biol. 2019 Apr;188:38-47. doi: 10.1016/j.jsbmb.2018.12.003. Epub 2018 Dec 6.

Abstract

Disorders featuring dysregulated adrenal steroidogenesis, such as primary aldosteronism, can benefit from targeted therapies. The aldosterone and cortisol producing enzymes, aldosterone synthase (CYP11B2) and 11-beta-hydroxylase (CYP11B1), share 93% homology requiring selective drugs for pharmacological treatment. Herein, we introduce an effective in vitro assay for evaluation of steroidogenic enzyme kinetics based on intracellular flux calculations. H295RA cells were cultured in chambers under constant medium flow. Four hourly samples were collected (control samples), followed by collections over an additional four hours after treatment with fadrozole (10 nM), metyrapone (10 μM), SI_191 (5 nM), a novel CYP11B2 inhibitor or SI_254 (100 nM), a newly synthesized 17-alpha-hydroxylase/17,20-lyase inhibitor. Mass spectrometric measurements of multiple steroids combined with linear system computational modeling facilitated calculation of intracellular fluxes and changes in rate constants at different steroidogenic pathway steps, enabling selectivity of drugs for those steps to be evaluated. While treatment with fadrozole, metyrapone and SI_191 all reduced fluxes of aldosterone, corticosterone and cortisol production, treatment with SI_254 led to increased flux through the mineralocorticoid pathway and reduced production of steroids downstream of 17-alpha-hydroxylase/17,20-lyase. Drug-induced decreases in rate constants revealed higher selectivity of SI_191 compared to other drugs for CYP11B2 over CYP11B1, this reflecting additional inhibitory actions of SI_191 on catalytic steps of CYP11B2 downstream from the initial 11-beta-hydroxlase step. By culturing cells under perfusion the described system provides a realistic model for simple and rapid calculations of intracellular fluxes and changes in rate constants, thereby offering a robust procedure for investigating drug or other effects at specific steps of steroidogenesis.

摘要

肾上腺类固醇生物合成失调的疾病,如原发性醛固酮增多症,可以受益于靶向治疗。醛固酮和皮质醇产生酶,醛固酮合酶(CYP11B2)和 11-β-羟化酶(CYP11B1),共享 93%的同源性,需要选择性药物进行药理学治疗。在此,我们介绍了一种基于细胞内流量计算评估类固醇生成酶动力学的有效体外测定法。H295RA 细胞在恒流介质下培养在室中。每隔四小时收集一次样本(对照样本),然后在另外四小时后收集样本,以进行 fadrozole(10 nM)、metyrapone(10 μM)、SI_191(5 nM)、一种新型 CYP11B2 抑制剂或 SI_254(100 nM)的处理,一种新合成的 17-α-羟化酶/17,20-裂合酶抑制剂。多种类固醇的质谱测量结合线性系统计算建模,便于计算不同类固醇生成途径步骤的细胞内流量和速率常数的变化,从而评估药物对这些步骤的选择性。虽然 fadrozole、metyrapone 和 SI_191 的处理均降低了醛固酮、皮质酮和皮质醇生成的流量,但 SI_254 的处理导致通过盐皮质激素途径的流量增加,并且降低了 17-α-羟化酶/17,20-裂合酶下游类固醇的生成。药物诱导的速率常数降低表明,与其他药物相比,SI_191 对 CYP11B2 相对于 CYP11B1 的选择性更高,这反映了 SI_191 对 CYP11B2 下游初始 11-β-羟化酶步骤的催化步骤的额外抑制作用。通过在灌流下培养细胞,该系统提供了一种简单快速计算细胞内流量和速率常数变化的现实模型,从而为研究类固醇生成特定步骤的药物或其他影响提供了一种稳健的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验